578 related articles for article (PubMed ID: 11650912)
1. Biotechnology and culture: the impact of public debates on government regulation in the United States and Denmark.
Baark E; Jamison A
Technol Soc; 1990; 12(1):27-44. PubMed ID: 11650912
[No Abstract] [Full Text] [Related]
2. State biotechnology oversight: the juncture of technology, law, and public policy.
Vito CC
Maine Law Rev; 1993; 45(2):329-83. PubMed ID: 11652701
[No Abstract] [Full Text] [Related]
3. The impact of activist pressures on recombinant DNA research.
Rabino I
Sci Technol Human Values; 1991; 16(1):70-87. PubMed ID: 11653926
[No Abstract] [Full Text] [Related]
4. Molecular biology or molecular politics? The production of scientific consensus on the hazards of recombinant DNA technology.
Wright S
Soc Stud Sci; 1986 Nov; 16(4):593-620. PubMed ID: 11650809
[No Abstract] [Full Text] [Related]
5. Living inventions: animal patenting in the United States and Europe.
Nelkin D
Stanford Law Pol Rev; 1992-1993 Winter; 4():203-10. PubMed ID: 11652651
[No Abstract] [Full Text] [Related]
6. The social warp of science: writing the history of genetic engineering policy.
Wright S
Sci Technol Human Values; 1993; 18(1):79-101. PubMed ID: 11652076
[No Abstract] [Full Text] [Related]
7. Recombinant DNA: triumph or Trojan horse?
Holtzman E
Man Med; 1977; 2(2):83-103, W7. PubMed ID: 12083131
[No Abstract] [Full Text] [Related]
8. Molecular politics in a global economy.
Wright S
Politics Life Sci; 1996 Sep; 15(2):249-63. PubMed ID: 11654797
[No Abstract] [Full Text] [Related]
9. How European and U.S. genetic engineering scientists view the impact of public attention on their field: a comparison.
Rabino I
Sci Technol Human Values; 1994; 19(1):23-46. PubMed ID: 11654086
[No Abstract] [Full Text] [Related]
10. Recombinant DNA and the regulation of biotechnology: reflections on the Asilomar Conference, ten years after.
Barkstrom JE
Akron Law Rev; 1985; 19(1):81-126. PubMed ID: 11650740
[No Abstract] [Full Text] [Related]
11. Threats and promises: negotiating the control of research.
Nelkin D
Daedalus; 1978; 107(2):191-209. PubMed ID: 11645789
[No Abstract] [Full Text] [Related]
12. How to keep out what we don't want: an assessment of 'Sozialverträglichkeit' under the Austrian Genetic Engineering Act.
Seifert F; Torgersen H
Public Underst Sci; 1997 Oct; 6(4):301-27. PubMed ID: 11655383
[No Abstract] [Full Text] [Related]
13. Genetic engineering and related biotechnologies: scientific progress and public policy.
Perpich JG
Technol Soc; 1983; 5(1):27-49. PubMed ID: 11650684
[No Abstract] [Full Text] [Related]
14. From Asilomar to industrial biotechnology: risks, reductionism and regulation.
Krimsky S
Sci Cult (Lond); 2005 Dec; 14(4):309-23. PubMed ID: 16619467
[No Abstract] [Full Text] [Related]
15. Coordinated framework for regulation of biotechnology; establishment of the Biotechnology Science Coordinating Committee; notice.
U.S. Office of Science and Technology Policy
Fed Regist; 1985 Nov; 50(220):47174-95. PubMed ID: 11655733
[No Abstract] [Full Text] [Related]
16. The challenge of biotechnology.
Gore A; Owens S
Yale Law Policy Rev; 1985; 3(2):336-57. PubMed ID: 11652468
[No Abstract] [Full Text] [Related]
17. U.S. resumes granting patents on genetically altered animals.
Andrews EL
N Y Times Web; 1993 Feb; ():A1, D5. PubMed ID: 11646960
[No Abstract] [Full Text] [Related]
18. Field-test ups and downs.
Sci News; 1986 Jun; 129(23):366. PubMed ID: 11653721
[No Abstract] [Full Text] [Related]
19. Molecular politics in Great Britain and the United States: the development of policy for recombinant DNA technology.
Wright S
South Calif Law Rev; 1978 Sep; 51(6):1383-434. PubMed ID: 11661660
[No Abstract] [Full Text] [Related]
20. Proposal for a coordinated framework for regulation of biotechnology.
U.S. Office of Science and Technology Policy
Fed Regist; 1984 Dec; 49(252):50856-907. PubMed ID: 11655658
[No Abstract] [Full Text] [Related]
[Next] [New Search]
